XBiotech
XBIT
34 hedge funds and large institutions have $11.4M invested in XBiotech in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
10% more funds holding
Funds holding: 31 → 34 (+3)
8% more capital invested
Capital invested by funds: $10.6M → $11.4M (+$819K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$936K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$856K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$783K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$698K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
+$325K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$477K |
| 2 |
Morgan Stanley
New York
|
-$227K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$19.9K |
| 4 |
Millennium Management
New York
|
-$9.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $16K | +$2.5K | +143 | +15% |
|
27
BNP Paribas Financial Markets
Paris,
France
| $14.1K | +$16.6K | +946 | New |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| $9K | – | – | – |
|
|
AA
29
ALPS Advisors
Denver,
Colorado
| $7.48K | +$325K | +18,596 | +59% |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | -$4.29K | -245 | -38% |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $16 | – | – | – |
|
|
VKH
32
Virtu KCG Holdings
New York
| – | -$477K | -26,366 | Closed |
|
|
33
UBS Group
Zurich,
Switzerland
| – | -$8K | -465 | Closed |
|
34
Invesco
Atlanta,
Georgia
| – | -$5K | -274 | Closed |
|
35
Wells Fargo
San Francisco,
California
| – | -$3.12K | -178 | -88% |
|
36
Bank of America
Charlotte,
North Carolina
| – | -$1.44K | -82 | -74% |
|
37
Citigroup
New York
| – | -$928 | -53 | -98% |
|
XBIT Hedge Fund Activity: Q3 2015 in Review
34 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q3 2015, worth a combined $11.4M — up 7.7% from $10.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new XBIT positions and 3 closed out — a net gain of 3 holders — while 10 added to existing stakes and 8 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $936K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $477K sold.
- 34 institutional investors held XBiotech (XBIT) as of Q3 2015, up from 31 in Q2 2015.
- Funds reported $11.4M of XBiotech stock for Q3 2015, up 7.7% quarter-over-quarter.
- 6 funds opened new XBiotech positions in Q3 2015 and 3 closed out, a net change of +3 holders.
- The largest XBiotech buyer in Q3 2015 was Goldman Sachs, an estimated $936K added.
- The largest XBiotech seller in Q3 2015 was Virtu KCG Holdings, an estimated $477K sold.
Based on aggregated 13F filings for Q3 2015.